Feature image

What's New

Warning: advertisements claiming Medsafe approval or bearing the Medsafe logo are scams

Medsafe is warning consumers and healthcare professionals that advertisements claiming Medsafe approval or bearing our logo are scams.

Medsafe never endorses or promotes any specific health product, service or brand.

Find out more

News and Events

Date Type Title
31/7/2025CommitteesMedicines Classification Committee - Dates and Deadlines
31/7/2025Monitoring CommunicationUpdate - Anti-CD20 monoclonal antibodies (rituximab, ocrelizumab, obinutuzumab, ofatumumab) and the possible risk of pyoderma gangrenosum
24/7/2025NoticesGuidelines and Application Form for Approval to Prescribe Psychedelics
23/7/2025ConsultationTopical corticosteroids: Proposal for the package labelling to state their potency - Consultation now closes on 13 August 2025
22/7/2025Alert CommunicationWarning: advertisements claiming Medsafe approval or bearing the Medsafe logo are scams
16/7/2025CommitteesComments on agenda items for the 74th meeting of the Medicines Classification Committee
1/7/2025CommitteesAgenda for the 126th meeting of the Medicines Assessment Advisory Committee to be held on 18 July 2025
30/6/2025CommitteesMelatonin without a prescription
24/6/2025ConsultationOutcome of the consultation on the proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD
12/6/2025NoticesMedsafe industry meetings May 2025
12/6/2025ConsultationProposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Bioequivalence of medicines
10/6/2025CommitteesMedicines Classification Committee - Dates and Deadlines
10/6/2025CommitteesAgenda for the 74th meeting of the Medicines Classification Committee to be held on 23 July 2025